Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of October 2015. The report addresses the status of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing.
Outlook, Risks, and Unusual Items
The Company convened its Annual General Meeting on October 15, 2015. However, the meeting was adjourned for one week due to a lack of quorum. The meeting is scheduled to be reconvened on Wednesday, October 22, 2015, at 10:00 am Israel time at the Company's offices in Petach Tikva, Israel.
Key Facts for Investors to Verify
- The Annual General Meeting originally scheduled for October 15, 2015, was adjourned due to lack of quorum.
- The reconvened meeting is set for October 22, 2015.
- This filing contains no financial performance data or updated guidance.